Skip to main content
OpenTrials
Completed

NCT Number: NCT02455102

Electronic Warning System for Atrial Fibrillation

The aim of this randomized controlled study is to evaluate whether a newly designed electronic warning system will increase the initiation rate of adequate stroke preventive measures in patients with atrial fibrillation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Swiss Cardiovascular Center, Inselspital, University of Bern

Bern, Canton of Bern, 3012, Switzerland

About this study

A large proportion of patients with atrial fibrillation do not receive stroke prevention therapy in line with the guidelines, in spite of the presence of an increased risk of stroke. It will be investigated whether an electronic alert to physicians, whose patients with atrial fibrillation do not receive stroke preventive measures, will increase the rate of adequate stroke preventive measures as compared to a control group of patients without an electronic alert. The electronic alerts will be sent if patients with atrial fibrillation but without adequate stroke preventive measures receive in-patient treatment at the University Hospital Bern. The electronic alert system includes a feature that helps the physicians in charge to evaluate the CHA2DS2VASC Score. At the end of the hospital stay medical discharge letters will be reviewed for initiation of adequate stroke preventive measures.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All in-patients with atrial fibrillation

Exclusion criteria

  • Ongoing anticoagulant therapy

Treatment and study plan

Electronic warning alert

Other

A newly-installed warning system for stroke prevention in atrial fibrillation.

Primary outcomes

  1. Rate of initiation of adequate measures to prevent stroke (oral anticoagulant prescription) by physician in charge

    Time frame: End of hospital stay (expected average duration of 1 week)

    Reviewed from discharge letter

Secondary outcomes

  1. Use of the CHA2DS2VASc score calculation tool by the physician in charge

    Time frame: During hospital stay (expected average duration of 1 week)

  2. Rate of correct evaluation of the CHA2DS2VASC Score through the calculation tool by physician in charge

    Time frame: End of hospital stay (expected average duration of 1 week)

Sponsors and collaborators

Lead sponsor

Insel Gruppe AG, University Hospital Bern

Other

Registry information

Official study title

Electronic Warning System to Improve Stroke Prevention in Atrial Fibrillation - A Quality Improvement Initiative at the University Hospital Bern

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
May 27, 2015
Registry last updated
Dec 22, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.